Effectiveness of a Cognitive Training Program (UMAM Method) in Elderly People Without Dementia
25 januari 2020 uppdaterad av: Madrid Salud
Cognitive Training in Elders Without Dementia Using UMAM Method. Genetic, Brain Volume and Cognitive Reserve Predictors: A Randomized Controlled Study
The study is oriented to analyze the effectiveness of a cognitive training method (UMAM) on cognitive functions, subjective memory and mood state in elderly people without dementia.
On the other hand, the study aims to examine whether variables such as cognitive reserve (e.g.
educational level), APOE genotype and intracranial volume are related to increased benefit after the intervention.
The researchers hope to find that greater cognitive reserve, not having the APOE allele ε4, and a greater volume of memory-related brain areas, are associated with better outcomes after the cognitive intervention.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
199
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Madrid, Spanien, 28006
- Centro de Prevención del Deterioro Cognitivo
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
60 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Being over 60 years old.
- Having a global cognitive performance > 23 in the Mini Mental State Examination Test.
- Having no history of neurological or serious psychiatric disorders (severe psycho-affective disorders and psychosis or other psychiatric disorders like alcoholism).
Exclusion Criteria:
- Chronic use of anxiolytics.
- Chronic use of neuroleptics.
- Chronic use of anticonvulsants.
- Having hearing or vision impairments that would preclude testing.
- Magnetic Resonance Imaging (MRI) contraindications.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Experimental Group
The experimental group carried out a 30-session multi-factorial group memory training program (UMAM method), with a frequency of three weekly sessions of 90 minutes each. The training program consists of four modules: 1- Stimulation of cognitive processes; learning and practicing internal memory strategies and solving everyday forgetfulness; 2- Instruction in basic concepts about memory; 3- Intervention on daily living and forgetting experiences, using internal and external strategies to solve everyday memory failures; 4- Metacognition or metamemory: the subjects were to reflect about their cognitive failures by analyzing the causes and variables of those failures. In addition, the experimental group followed the standard activities in which all users attending the Center are involved (planned interviews, dialogue-conferences, general health recommendations, etc.). |
|
|
Inget ingripande: Control Group
The Control Group followed the standard activities in which all users attending the Center are involved (planned interviews, dialogue-conferences, general health recommendations, etc.).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in general cognition
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in general cognition, assessed with the Mini Mental State Examination Test (MMSE) and the 7 Minutes Test (7M).The score ranges from 0 to 30 points (MMSE) and from 0 to 89 points (7M).
In both cases, the higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in verbal memory
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in verbal memory, assessed with the Word List Test of the Wechsler Memory Scale-III.
The score ranges from 0 to 48 points.
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in logical memory
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in immediate and delayed logical memory, assessed with the Logical Memory Test (immediate and delayed units) of the Wechsler Memory Scale-III.
The score ranges from 0 to 75 points (immediate units) and from 0 to 50 (delayed units).
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in visual memory
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in visual memory, assessed with the Rey memory test (form B).
The score ranges from 0 to 22 points.
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in daily memory
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in daily memory, assessed with the Rivermead Behavioral Memory Test.
The score ranges from 0 to 24 points.
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in attentional amplitude
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in attentional amplitude, assessed with the Direct Digit Test of the Wechsler Memory Scale-III.
The score ranges from 0 to 16 points.
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in attentional control
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in attentional control, assessed with the Inverse Digit Test of the Wechsler Memory Scale-III.
The score ranges from 0 to 14 points.
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in attention and processing speed
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in attention, assessed with the Trail Making Test, form A. The score ranges from 0 to 200 points.
Higher scores indicate a worse outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in alternating attention and planning
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in alternating attention and planning, assessed with the Trail Making Test, form B. The score ranges from 0 to 400 points.
Higher scores indicate a worse outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in naming ability (language)
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in naming ability, assessed with the Boston Naming Test.
The score ranges from 0 to 60 points.
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in verbal fluency (language)
Tidsram: This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in phonologic and semantic verbal fluency, assessed with the Phonological Verbal Fluency Test and the Semantic Fluency Test respectively.
The score goes from zero onwards (there is no upper limit).
Higher scores indicate a better outcome.
|
This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in subjective memory
Tidsram: This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in Subjective Memory, assessed with the Memory Failures of Everyday Questionnaire.The score ranges from 0 to 56 points.
Higher scores indicate a worse outcome.
|
This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
Change in mood
Tidsram: This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
The measure of the post-intervention change in mood, assessed with the Geriatric Depression Scale.
The score ranges from 0 to 15 points.
Higher scores indicate a worse outcome.
|
This variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.
|
|
The Cognitive Reserve as a predictor of change.
Tidsram: Cognitive Reserve was assessed in the pre-intervention assessment.
|
The Cognitive Reserve was assessed with Rami Test.
The score ranges from 0 to 25 points.
|
Cognitive Reserve was assessed in the pre-intervention assessment.
|
|
The Genetic Profile as a predictor of change.
Tidsram: The Genetic Profile was assessed in the pre-intervention assessment.
|
The Genetic Profile was obtained by genetic analysis employing a blood test.
APOE gene has been coded as 1 (meaning no ε4 allele), or 0 (for at least one ε4 allele).
|
The Genetic Profile was assessed in the pre-intervention assessment.
|
|
The Brain Volume as a predictor of change.
Tidsram: The Brain Volume was assessed in the pre-intervention assessment.
|
The Brain Volume (total gray volume, left hippocampus, right hippocampus and total intracranial volume) was assessed by magnetic resonance imaging.
Unit of measure: mm3.
|
The Brain Volume was assessed in the pre-intervention assessment.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 oktober 2013
Primärt slutförande (Faktisk)
1 maj 2015
Avslutad studie (Faktisk)
1 maj 2015
Studieregistreringsdatum
Först inskickad
22 december 2019
Först inskickad som uppfyllde QC-kriterierna
25 januari 2020
Första postat (Faktisk)
29 januari 2020
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
29 januari 2020
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
25 januari 2020
Senast verifierad
1 januari 2020
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 15/382-E_BS
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Nej
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
produkt tillverkad i och exporterad från U.S.A.
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .